“The delay on the Tagrisso drug price negotiation is no special treatment”
While the drug price negotiation for ‘Tagrisso,’ a non-small cell lung cancer treatment, has made various issues, the National Health Insurance Service(NHIS) clarified them.
In a statement of clarifying them on the 26th, the NHIS said “We are carrying out the negotiation fairly under the drug pr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
